23 Jul, 2026
According to Straits Research, the global capnography market valued at $1,057.1 million in 2025, is projected to grow from $1,200.87 million in 2026 to $3,330.6 million by 2034 at a CAGR of 13.6% during the forecast period 2026–2034.
Capnography is the measurement and analysis of the carbon dioxide content of respiratory gases using capnograph devices. It is essential to measure the actual blood carbon dioxide levels. Capnographs are used to measure carbon dioxide levels during inhalation and exhalation.
The need for intensive care units has increased due to recent trends in illnesses and accidents (ICUs). These services' primary attributes include access to patient data and ongoing monitoring. This expedites clinical decision-making and encourages efficient healthcare delivery. The use of these systems also jeopardizes patient care. The stabilization of acute or life-threatening medical problems, the comprehensive management of injury or illness, and the maximization of comfort for dying patients are additional reasons why more than 5 million patients are admitted to ICUs each year in the United States. As a result, it is anticipated that all the factors above will promote market growth.
The capnography market currently has the most extensive customer base in North America. The American Heart Association estimates that heart disease claims the lives of 647,000 Americans annually. Furthermore, according to the American Lung Association (ALA), 16 million adults in the U.S. have COPD. Additionally, growth is anticipated in developing countries like the U.S. and Mexico due to advancements in the healthcare infrastructure, rising healthcare costs, and greater public awareness of diseases like cancer and cardiovascular disease. It is predicted that rising personal disposable income and healthcare costs in developing nations will create lucrative opportunities for global capnography market growth.
North America is the most significant contributor to the global capnography market and is expected to grow at a CAGR of 12.6% during the forecast period. Increasing numbers of elderly people and COPD cases with complications are primarily responsible for this growth. It is anticipated that the rising use of sophisticated capnography devices, both portable and non-portable, as well as advancements in capnography monitors, will spur market expansion. In addition, the healthcare systems, facilities, and payers in North America are well-regarded. More advanced healthcare services and cutting-edge diagnostic and therapeutic tools are required as the prevalence of health-related diseases and disorders rises. Additionally, there are more job opportunities in the region as the demand for highly qualified medical professionals to operate these increases.
Europe is expected to grow at a CAGR of 13.8% during the forecast period. The European Resuscitation Council (ERC), the Association of Anesthetists of Great Britain and Ireland (AAGBI), and the Intensive Care Society in the UK all endorse the use of capnography devices. The market for capnography devices is also anticipated to be boosted by rising rates of conditions like respiratory, cardiovascular, and asthma, as well as surgeries in Europe, particularly in the UK, France, Germany, Italy, Spain, and other countries in the continent. In addition, the increased use of capnography in X-ray rooms, endoscopic suites, on-site emergency rooms, and trauma centers is helping the market grow. Market growth is also anticipated to be fueled by rising disposable income and healthcare spending by public and private organizations.
sales@straitsresearch.com